PDEX vs SYK
PDEX: Pro-Dex designs and manufactures precision surgical handpieces and medical devices, while expanding into aerospace machining through its recent acquisition of APM. SYK: A diversified global MedTech leader providing surgical instruments, robotics, and advanced clinical technologies to enhance patient recovery and healthcare outcomes.
Side-by-side fundamentals
| Metric | PDEX | SYK | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $62.21 | $276.97 | |
| Market cap | $199M | $106.2B | |
| P/E as of 2026-10-08 | 17.16 | 28.70 | PDEX lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 2.65 | |
| Net margin | +17.6% | +12.9% | PDEX higher |
| Gross margin | +31.4% | +64.0% | SYK higher |
| Operating margin | +16.8% | +19.5% | SYK higher |
| ROE | +28.7% | +14.5% | PDEX higher |
| ROA | +18.3% | +6.8% | PDEX higher |
| Debt / equity as of 2026-09-02 | 0.41 | 0.62 | PDEX lower |
| Revenue growth (YoY) as of 2026-09-02 | +16.4% | +8.5% | PDEX higher |
| Revenue CAGR (3y) SEC XBRL | +18.9% | +10.8% | PDEX higher |
| Dividend yield as of 2026-09-02 | n/a | +1.3% | |
| Dividend streak (yrs) SEC XBRL | 0 | 8 | SYK higher |
| Beta as of 2026-09-02 | 0.70 | 0.56 | |
| 1-year return as of 2026-10-08 close | +79.1% | -26.2% | PDEX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.